我的购物车

Integrin α 4 β 7 : MAdCAM-1 [Biotinylated] Inhibitor Screening ELISA Kit

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车

产品详情

  • 组分(Materials Provided)

    ID
    Components
    Size
    EP155-C01
    High-bind Plate
    1 plate
    EP155-C02
    Human Integrin α 4 β 7
    25 μg
    EP155-C03
    Biotinylated Human MAdCAM-1
    10 μg
    EP155-C04
    Anti-Integrin α 4 β 7 Neutralizing Antibody
    20 μg
    EP155-C05
    Streptavidin-HRP
    5 μg
    EP155-C06
    Coating Buffer
    12 mL
    EP155-C07
    10xWashing Buffer
    50 mL
    EP155-C08
    Blocking Buffer
    50 mL
    EP155-C09
    Substrate Solution
    12 mL
    EP155-C10
    Stop Solution
    7 mL
    EP155-C11
    1mol/L CaCl₂
    1.5 mL
    EP155-C12
    1mol/L MgCl₂
    1.5 mL
    EP155-C13
    1mol/L MnCl₂
    1.5 mL

  • 产品概述(Product Overview)

    The integrin α4β7 is heterodimeric cell surface receptors expressed on most leukocytes. Mucosal addressing cell adhesion molecule 1(MAdCAM-1) is an exclusive ligand for α4β7 integrin. The interaction of integrin α4β7 with addressin mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is central to IBD pathogenesis.

  • 应用说明(Application)

    This kit is developed for screening for inhibitors of human Integrin α 4 β 7 binding to human MAdCAM-1.

    It is for research use only.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • 存储(Storage)

    Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • 原理(Assay Principles)

    This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new Integrin α 4 β 7 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human MAdCAM-1 to immobilized human Integrin α 4 β 7 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated MAdCAM-1 protein, a human Integrin α 4 β 7 protein, an anti-Integrin α 4 β 7 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    a) Coat the plate with human Integrin α 4 β 7.

    b) Add your molecule of interest to the tests.

    c) Add human MAdCAM-1-Biotin to bind the coated Integrin α 4 β 7.

    d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the half maximal inhibitory concentration (IC50) of your compound to Integrin α 4 β 7:MAdCAM-1 binding will be determined by comparing OD readings among different experimental groups.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 典型数据-Typical Data

    Please refer to DS document for the assay protocol.

     Integrin alpha 4 beta 7 TYPICAL DATA

    INHIBITION OF Integrin α 4 β 7: MAdCAM-1 [Biotinylated] BINDING BY ANTI-Integrin α 4 β 7 NEUTRALIZING ANTIBODY
    Serial dilutions of Anti-Integrin α 4 β 7 Neutralizing antibody (Catalog # EP155-C04) (1:1 serial dilution, from 5 μg/mL to 0.0098μg/mL) was added into Integrin α 4 β 7: Biotinylated MAdCAM-1 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

  •  Integrin alpha 4 beta 7 TYPICAL DATA

    INHIBITION OF Integrin α 4 β 7: MAdCAM-1 [Biotinylated] BINDING BY selective α4 integrin antagonist
    Serial dilutions of selective α4 integrin antagonist (1:1 serial dilution, from 10 μg/mL to 0.1526μg/mL) was added into Integrin α 4 β 7: Biotinylated MAdCAM-1 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (Routinely tested).

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Integrin alpha-4/beta-7

  • 中文全称:

    整合素α-4/β-7复合体

  • 种类:

  • 上市药物数量:

    4 详情

  • 临床药物数量:

    11 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价